Fintech Observers Comment on SpaceX IPO

As the SpaceX IPO continues to spark global market debate, Crowdfund Insider brings together fintech and investment commentators to assess what this listing could mean for public markets, innovation, and investor appetite.

Sean Peche, Portfolio Manager at Ranmore Fund Management, draws a parallel to purchasing Pfizer shares in April of 1998. Bloomberg indicates the total return would have been a negative 26% over 28 years.

Read more here: Fintech Observers Comment On SpaceX IPO | Crowdfund Insider

More coverage below:

Bezinga	https://www.benzinga.com/markets/ipos/26/06/53168902/spacex-ipo-value-investors-100-times-sales
Day Traders	https://daytraders.com/news/2026/06/12/spacex-ipo-value-investors-100-times-sales
Daily Hunt	https://m.dailyhunt.in/news/india/english/benzinga-epaper-benzinga/value+investors+question+spacexs+record+ipo+its+the+future+that+kills+you-newsid-n715846990
PWS	https://www.pws.io/value-investors-question-spacexs-record-ipo-its-the-future-that-kills-you
Trustnet	https://www.trustnet.com/news/13478756/after-the-ipo-spacex-is-a-great-company-but-is-it-a-great-investment